Yuanyu Huang is a Professor at the Advanced Research Institute of Multidisciplinary Science and the School of Life Science at Beijing Institute of Technology. With a Ph.D. in Biotechnology from Peking University and postdoctoral experience there, he specializes in nucleic acid-based therapeutics, focusing on design, optimization, and delivery systems for molecules like siRNA, mRNA, Aptamer, and CRISPR/Cas. He serves in various leadership roles in prestigious academic organizations and is an Associate Editor for Exploration (Wiley) and Editorial Board Member for several journals. His research has yielded over 120 peer-reviewed papers in renowned journals, alongside numerous patents and invitations to review manuscripts for top-tier publications.
Professional Profile:
Scopus
Orcid
š Education and Work Experiences:
Dr. Yuanyu Huang, currently a Full Professor at the Beijing Institute of Technology, has an extensive academic journey spanning prestigious institutions in China. Beginning his academic pursuit, he earned his Bachelor of Science degree in Biotechnology from Central South University in 2008. Subsequently, he pursued his doctoral studies at Peking University, where he obtained his Ph.D. in Biotechnology in 2013. Following this, he continued his research at Peking University as a Postdoctoral Research Fellow until 2016
šØāš¬ Membership in Academic Organizations:
Dr. Yuanyu Huang holds esteemed positions within several prominent academic organizations in China, reflecting his active involvement and leadership in the scientific community. As the Secretary General and Council Member of the Chinese Association of Nanobiology, Biophysical Society of China, he plays a pivotal role in promoting advancements at the intersection of nanobiology and biophysics. Additionally, Dr. Huang serves as a Council Member of the China Vaccine Industry Association, Vaccine Basic Research Committee, contributing his expertise to the forefront of vaccine research and development. His dedication extends to the Chinese Society for Biomaterials, Smart Biomimetic Biomaterials Branch, where he holds a Council Member position, driving innovation in biomaterials design and application
š Academic Achievements:
Dr. Huang focuses on nucleic acid-based therapeutics, drug delivery systems, and translational medicine. He has published 120+ peer-reviewed papers in renowned journals and holds 40+ patents, with over 6000 citations. Dr. Huang serves as a referee for 60+ journals, including Nature Chemical Biology and Science Advances.